Eisai-Biogen Alzheimer's drug Lecanemab should be priced below Aduhelm: Report Ruchika Sharma25 Dec 2022 8:30 AM GMTTreatment with the drug may provide a small or even substantial benefit to patients with early Alzheimer's, but there remains a possibility of net...
Lupin rolls out Seizure drug Rufinamide in US Ruchika Sharma5 Dec 2022 9:45 AM GMTMumbai: Pharma major Lupin Limited today announced the launch of Rufinamide Tablets USP, 200 mg and 400 mg in the United States market.The...
Roche to stop all Gantenerumab studies in early Alzheimer's disease Ruchika Sharma2 Dec 2022 9:00 AM GMTRoche is still testing a different formulation of gantenerumab called trontinemab, designed to ferry the drug across the blood brain barrier -...
Lupin bags USFDA okay for seizure treatment drug Rufinamide Ruchika Sharma18 Aug 2022 9:53 AM GMTRufinamide Tablets will be manufactured at Lupin’s facility in Goa, India.
USFDA decision on Eisai, Biogen Alzheimer's drug due in January Ruchika Sharma6 July 2022 4:30 AM GMTEisai in March downsized its role in Aduhelm, but remains the leader in the 50-50 partnership's lecanemab program.
Eisai gets Japanese orphan drug designation for ultrahigh-dose mecobalamin with prospective indication for functional impairment of amyotrophic lateral sclerosis Ruchika Sharma30 May 2022 5:30 AM GMTALS is an intractable, progressive, neurodegenerative disease that results in severe muscle atrophy and weakness in the muscles due to motor neuron...
Merck, Eisai get Japanese nod for cancer cocktail drug Keytruda, Lenvima Ruchika Sharma30 Dec 2021 6:52 AM GMTKenilworth: Merck, known as MSD outside the United States and Canada, and Eisai have announced that the Japanese Ministry of Health, Labour and...
Biogen gets USFDA Fast Track designation for lecanemab Ruchika Sharma26 Dec 2021 4:00 AM GMTTokyo: Eisai Co., Ltd. and Biogen Inc. have announced that lecanemab, an investigational anti-amyloid beta (Aβ) protofibril antibody for the...
Dr Reddys, Citius Pharma ink pact to sell rights to anti-cancer agent Ruchika Sharma4 Sep 2021 11:22 AM GMTHyderabad: Dr Reddy's Laboratories Ltd., announced that the company has entered into a definitive agreement with Citius Pharmaceuticals, Inc....
Bristol-Myers, Eisai in up to USD 3.1 billion deal to develop cancer drug candidate Medical Dialogues Team19 Jun 2021 5:30 AM GMTNew Delhi: Bristol-Myers Squibb Co and Eisai Co said on Thursday they had entered into an agreement worth up to USD 3.10 billion to jointly develop...
Biogen, Eisai secure USFDA accelerated nod for Alzheimer drug ADUHELM Ruchika Sharma8 Jun 2021 10:27 AM GMTCambridge: Biogen and Eisai, Co., Ltd. have announced that the U.S. Food and Drug Administration (USFDA) has granted accelerated...
